SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is trending as investors bet on an oil supply squeeze driven by intensifying geopolitical conflict in the Middle East and the closure of major shipping straits. The community is actively discussing the stock's potential as a short-squeeze candidate, with many expressing bullish sentiment on energy prices and debating the impact of ongoing regional escalations on oil infrastructure.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is currently trending as investors debate its long-term AI growth potential against short-term risks from Middle East conflict-driven cloud disruptions and regional volatility. While community sentiment remains split, bulls are actively highlighting aggressive analyst price targets and potential infrastructure buildouts as reasons to accumulate on dips, while bears are focused on bearish technical flow and concerns over macroeconomic headwinds.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility versus short-term price action, with significant focus on an upcoming token unlock and high expectations for major partnerships in the pipeline. Investors are actively discussing the project's potential integration with institutional rails like XRP and Stellar, fueling a narrative of long-term holding despite current market volatility.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB) is trending as the community actively pushes for new exchange listings and chart integrations for associated projects like Maulcoin. Investors are maintaining a focus on long-term growth and utility, while the community continues to rally around the project's ecosystem development and expansion efforts.

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF is seeing significant momentum as investors capitalize on surging global military spending and persistent geopolitical tensions, with many in the community viewing it as a strategic long-term play for aerospace and autonomous technology. Traders are actively debating the integration of artificial intelligence and robotics into defense platforms, with many highlighting the ETF's diversified exposure to both domestic and international contractors as a key hedge against macroeconomic uncertainty.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh strong 1Q26 booking momentum and expanding defense sector partnerships against disappointing quarterly revenue and wider-than-expected losses. The community is actively debating the stock's long-term valuation as a speculative "quantum pure-play" while navigating intense volatility driven by competitive pressures from other industry players and broader macroeconomic uncertainty.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is trending due to surging interest in its European gas fields amid heightened geopolitical instability and supply concerns in the energy sector. Investors are closely monitoring the stock's tight float and high cost-to-borrow fees, with community discussions heavily focused on the potential for a short squeeze and the added leverage provided by the company's warrants.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy is capturing significant market attention following its recent NASDAQ debut and business combination, with the community actively debating the company's potential to unlock massive oil reserves in the Arctic. Traders are closely monitoring the stock's high volatility and thin-float dynamics while weighing the ambitious drilling plans against the speculative risks of a frontier energy project.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant community attention as traders debate its role in institutional adoption, with many users actively discussing its potential for recovery amidst broader crypto market volatility. Community sentiment remains polarized, featuring a mix of long-term holders focused on staking and developers pushing various meme-based projects on the chain.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors react to a significant analyst upgrade and anticipate the upcoming presentation of Phase 3 long-term clinical data at the American Academy of Dermatology conference. The community is actively discussing the stock's potential for acquisition, with ongoing debates centered on whether recent price volatility is driven by institutional accumulation or tactical suppression by market makers.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm Therapeutics (KPTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Esperion Therapeutics (NASDAQ:ESPR) Share Price Crosses Below 200 Day Moving Average - Time to Sell?

Esperion Therapeutics (NASDAQ:ESPR) Stock Passes Below Two Hundred Day Moving Average - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Insider Sells $15,411.60 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) insider Benjamin Looker sold 5,708 shares of Esperion Therapeutics stock in a transaction dated Tuesday, March 17th. The shares were sold...

Insider Selling: Esperion Therapeutics (NASDAQ:ESPR) Insider Sells $15,411.60 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) insider Benjamin Looker sold 5,708 shares of Esperion Therapeutics stock in a transaction dated Tuesday, March 17th. The stock was sold at...

Esperion Therapeutics (NASDAQ:ESPR) CFO Sells $17,409.04 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 6,424 shares of the company's stock in a transaction on Tuesday, March 17th. The stock was sold at an average...

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Down 7.6% - Here's What Happened

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Down 7.6% - Time to Sell...

Q1 EPS Estimate for Esperion Therapeutics Lowered by Analyst

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Investment analysts at HC Wainwright cut their Q1 2026 earnings per share estimates for Esperion Therapeutics in a research report issued on...

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Up 7.8% Following Analyst Upgrade

Esperion Therapeutics (NASDAQ:ESPR) Shares Up 7.8% After Analyst Upgrade...

Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference

Executives from Esperion Therapeutics (NASDAQ:ESPR) highlighted accelerating revenue growth, plans to expand its commercial footprint, and details of a pending acquisition during remarks at the...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ESPR News

ESPREsperion Therapeutics Inc.